← back to search

Christopher E. Buller

Teleflex (United States) · US
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, and Mechanical Circulatory Support Devices.
h-index
66
citations
24,022
works
197
NIH funding
primary concept
Medicine
email

Recent publications

Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions
Heart Lung and Circulation 2024cited by 14position: middledoi
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations
Circulation 2021cited by 282position: middledoi
Global Chronic Total Occlusion Crossing Algorithm
Journal of the American College of Cardiology 2021cited by 226position: middledoi
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
Circulation 2019cited by 430position: middledoi
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers
JACC: Cardiovascular Interventions 2019cited by 244position: middledoi
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
JACC: Cardiovascular Interventions 2019cited by 35position: middledoi
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes
JACC: Cardiovascular Interventions 2018cited by 145position: middledoi
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
The Lancet 2015cited by 147position: middledoi
Spontaneous Coronary Artery Dissection
JACC: Cardiovascular Interventions 2012cited by 387position: lastdoi
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial
European Heart Journal 2012cited by 106position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gilles Montalescot · ACTION1 papers (2012–2012) · 1 papers (2012–2012)Michael Ring · Houston Methodist1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2012–2012)Andrew Starovoytov · University of British Columbia1 papers (2012–2012)Jacqueline Saw · University of British Columbia Hospital1 papers (2012–2012)John H. Alexander · Duke University Hospital1 papers (2012–2012)Jarosław D. Kasprzak · Mossakowski Medical Research Institute, Polish Academy of Sciences1 papers (2012–2012)Uwe Zeymer · German Cardiac Society1 papers (2012–2012)Rebecca Fox · Medical University of South Carolina1 papers (2012–2012)Richard C. Becker · University of Cincinnati1 papers (2012–2012)Christoph Bode · University of Freiburg1 papers (2012–2012) · 1 papers (2012–2012)Andrzej Rynkiewicz · University of Computer Sciences and Economics in Olsztyn1 papers (2012–2012)Madhu K. Natarajan · Hamilton General Hospital1 papers (2012–2012)Thomas J. Povsic · Clinical Research Institute1 papers (2012–2012)Donald R. Ricci · University of British Columbia1 papers (2012–2012)Mauricio G. Cohen · Cleveland Clinic Florida1 papers (2012–2012)Roxana Mehran · Icahn School of Medicine at Mount Sinai1 papers (2012–2012)